Over 3,000 product registrations fuel long-term growth visibility

Sharda Cropchem Limited today announced its audited consolidated financial results for the quarter and year ended March 31, 2026, reporting a landmark performance driven by strong agrochemical demand, improved product mix, and accelerating contributions from its expanding global product registration pipeline.

For FY26, the company recorded consolidated revenue of Rs 5,268 crore, marking a growth of 22 per cent year-on-year, supported by robust volume expansion and a higher-value product portfolio across key international markets.

EBITDA rose sharply by 69 per cent to Rs 1,040 crore, with margins expanding to 19.7 per cent, reflecting operating leverage and improved execution efficiency. Profit After Tax more than doubled to Rs 681 crore, registering a strong increase of 124 per cent over the previous year.

The company also achieved its highest-ever Return on Capital Employed (RoCE) of 30.4 per cent, underscoring the strength of its asset-light business model and disciplined capital allocation strategy.

Management Commentary

Commenting on the results, Ramprakash Bubna, Chairman and Managing Director, described FY26 as a landmark year for the company, driven by sustained volume momentum, improved product mix, and the scaling impact of its global registration strategy. He noted that investments in product registrations are increasingly translating into sustainable revenue growth across geographies.

He further highlighted that the company’s strong operating performance reflects the benefits of scale, efficiency gains, and a structurally resilient business model, positioning the organisation well for continued momentum into FY27.

Segment Performance

The agrochemical segment remained the dominant contributor, accounting for 93 per cent of Q4 revenue and 90 per cent of FY26 revenue, with overall agrochemical volumes growing strongly during the year. The non-agrochemical segment also contributed to growth, supported by diversified product demand.

Operational Highlights

During FY26, overall volumes increased by 13.4 per cent, driven primarily by agrochemical expansion. The company continued to strengthen its global footprint, supported by an expanding portfolio of product registrations, which reached 3,011, with over 1,004 applications pending across various stages of approval as of March 31, 2026.

Capital expenditure for FY26 stood at Rs 505 crore, reflecting continued investment in growth initiatives and market expansion. The company also maintained a strong balance sheet, remaining debt-free with cash, bank balances, and liquid investments of Rs 702 crore.

Dividend

The Board of Directors has recommended a final dividend of Rs 9 per equity share (90 per cent of face value). Including the interim dividend of Rs 6 per equity share paid in December 2025, the total dividend for FY26 amounts to Rs 15 per share.

Outlook

Sharda Cropchem stated that it enters FY27 with strong operational momentum, a robust registration pipeline, and an expanding global presence. The company expressed confidence in sustaining its growth trajectory, supported by continued execution discipline and a resilient, scalable business model in the global crop protection chemicals industry.